Table of Contents

1 Product Introduction and Overview

• 1.1 Product Definition
• 1.2 Product Specification
• 1.3 Global Market Overview
  • 1.3.1 Global Sacral Nerve Stimulation Market Status and Forecast (2016-2027)
  • 1.3.2 Global Sacral Nerve Stimulation Sales Value CAGR by Region
• 1.4 Market Drivers, Inhibitors
  • 1.4.1 Market Drivers
  • 1.4.2 Market Inhibitors
  • 1.4.3 COVID-19 Impact Analysis

2 Global Sacral Nerve Stimulation Supply by Company

• 2.1 Global Sacral Nerve Stimulation Sales Value by Company
• 2.2 Sacral Nerve Stimulation Sales Area of Main Manufacturers
• 2.3 Trend of Concentration Rate

3 Global and Regional Sacral Nerve Stimulation Market Status by Category

• 3.1 Sacral Nerve Stimulation Category Introduction
  • 3.1.1 Implantable SNS
  • 3.1.2 External SNS
• 3.2 Global Sacral Nerve Stimulation Market by Category
• 3.3 North America: by Category
• 3.4 Europe: by Category
• 3.5 Asia Pacific: by Category
• 3.6 Central & South America: by Category
• 3.7 Middle East & Africa: by Category

4 Global and Regional Sacral Nerve Stimulation Market Status by End User/Segment

• 4.1 Sacral Nerve Stimulation Segment by End User/Segment
  • 4.1.1 Hospitals
  • 4.1.2 Clinics
  • 4.1.3 ASCs
• 4.2 Global Sacral Nerve Stimulation Market by End User/Segment
• 4.3 North America: by End User/Segment
• 4.4 Europe: by End User/Segment
• 4.5 Asia Pacific: by End User/Segment
• 4.6 Central & South America: by End User/Segment
• 4.7 Middle East & Africa: by End User/Segment

5 Global Sacral Nerve Stimulation Market Status by Region

• 5.1 Global Sacral Nerve Stimulation Market by Region
• 5.2 North America Sacral Nerve Stimulation Market Status
• 5.3 Europe Sacral Nerve Stimulation Market Status
• 5.4 Asia Pacific Sacral Nerve Stimulation Market Status
• 5.5 Central & South America Sacral Nerve Stimulation Market Status
• 5.6 Middle East & Africa Sacral Nerve Stimulation Market Status

6 North America Sacral Nerve Stimulation Market Status

• 6.1 North America Sacral Nerve Stimulation Market by Country
• 6.2 United States
• 6.3 Canada
• 6.4 Mexico

7 Europe Sacral Nerve Stimulation Market Status

• 7.1 Europe Sacral Nerve Stimulation Market by Country
• 7.2 Germany
• 7.3 France
• 7.4 UK
• 7.5 Italy
• 7.6 Russia
• 7.7 Spain

8 Asia Pacific Sacral Nerve Stimulation Market Status

• 8.1 Asia Pacific Sacral Nerve Stimulation Market by Country
• 8.2 China
• 8.3 Japan
• 8.4 Korea
• 8.5 Southeast Asia
• 8.6 India
• 8.7 Australasia

9 Central & South America Sacral Nerve Stimulation Market Status

• 9.1 Central & South America Sacral Nerve Stimulation Market by Country
• 9.2 Brazil
• 9.3 Argentina
• 9.4 Colombia

10 Middle East & Africa Sacral Nerve Stimulation Market Status

• 10.1 Middle East & Africa Sacral Nerve Stimulation Market by Country
• 10.2 Iran
• 10.3 Israel
• 10.4 Turkey
• 10.5 South Africa
• 10.8 Saudi Arabia

11 Major Downstream Customers Analysis

• 11.1 Customer One Analysis
• 11.2 Customer Two Analysis
• 11.3 Customer Three Analysis
• 11.4 Customer Four Analysis

12 Global Sacral Nerve Stimulation Market Forecast by Category and by End User/Segment

• 12.1 Global Sacral Nerve Stimulation Sales Value Forecast (2022-2027)
• 12.2 Global Sacral Nerve Stimulation Forecast by Category
• 12.3 Global Sacral Nerve Stimulation Forecast by End User/Segment

13 Global Sacral Nerve Stimulation Market Forecast by Region/Country

• 13.1 Global Sacral Nerve Stimulation Market Forecast by Region (2022-2027)
• 13.2 North America Market Forecast
• 13.3 Europe Market Forecast
• 13.4 Asia Pacific Market Forecast
• 13.5 Central & South America Market Forecast
• 13.6 Middle East & Africa Market Forecast

14 Key Participants Company Information

• 14.1 Uroplasty, Inc
  • 14.1.1 Company Information
  • 14.1.2 Sacral Nerve Stimulation Product Introduction
  • 14.1.3 Uroplasty, Inc Sacral Nerve Stimulation Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.1.4 SWOT Analysis
• 14.2 Nuvectra
  • 14.2.1 Company Information
  • 14.2.2 Sacral Nerve Stimulation Product Introduction
  • 14.2.3 Nuvectra Sacral Nerve Stimulation Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.2.4 SWOT Analysis
• 14.3 Neuropace
  • 14.3.1 Company Information
  • 14.3.2 Sacral Nerve Stimulation Product Introduction
  • 14.3.3 Neuropace Sacral Nerve Stimulation Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.3.4 SWOT Analysis
• 14.4 Medtronic
  • 14.4.1 Company Information
  • 14.4.2 Sacral Nerve Stimulation Product Introduction
  • 14.4.3 Medtronic Sacral Nerve Stimulation Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.4.4 SWOT Analysis
• 14.5 IntraPace, Inc
  • 14.5.1 Company Information
  • 14.5.2 Sacral Nerve Stimulation Product Introduction
  • 14.5.3 IntraPace, Inc Sacral Nerve Stimulation Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.5.4 SWOT Analysis
• 14.6 Cyberonics
  • 14.6.1 Company Information
  • 14.6.2 Sacral Nerve Stimulation Product Introduction
  • 14.6.3 Cyberonics Sacral Nerve Stimulation Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.6.4 SWOT Analysis
• 14.7 Cogentix Medical
  • 14.7.1 Company Information
  • 14.7.2 Sacral Nerve Stimulation Product Introduction
  • 14.7.3 Cogentix Medical Sacral Nerve Stimulation Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.7.4 SWOT Analysis
• 14.8 Codman & Shurtleff, Inc
  • 14.8.1 Company Information
  • 14.8.2 Sacral Nerve Stimulation Product Introduction
  • 14.8.3 Codman & Shurtleff, Inc Sacral Nerve Stimulation Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.8.4 SWOT Analysis
• 14.9 Boston Scientific
  • 14.9.1 Company Information
  • 14.9.2 Sacral Nerve Stimulation Product Introduction
  • 14.9.3 Boston Scientific Sacral Nerve Stimulation Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.9.4 SWOT Analysis
• 14.10 Axonics Modulation Technologies
  • 14.10.1 Company Information
  • 14.10.2 Sacral Nerve Stimulation Product Introduction
  • 14.10.3 Axonics Modulation Technologies Sacral Nerve Stimulation Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.10.4 SWOT Analysis
• 14.11 Abbott

15 Conclusion

16 Methodology

Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Sacral Nerve Stimulation market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Sacral Nerve Stimulation market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

Segmented by Category
Implantable SNS
External SNS

Segmented by End User/Segment
Hospitals
Clinics
ASCs

Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia

Key manufacturers included in this survey
Uroplasty, Inc
Nuvectra
Neuropace
Medtronic
IntraPace, Inc
Cyberonics
Cogentix Medical
Codman & Shurtleff, Inc
Boston Scientific
Axonics Modulation Technologies
Abbott